Literature DB >> 35350173

Economic Burden of Fungal Diseases in the United States.

Kaitlin Benedict1, Hilary K Whitham1, Brendan R Jackson1.   

Abstract

We conservatively estimated the US economic burden of fungal diseases as $11.5 billion in 2019: direct medical costs ($7.5 billion), productivity loss due to absenteeism ($870 million), and premature deaths ($3.2 billion). An alternative "value of statistical life" approach yielded >$48 billion. These are likely underestimates given underdiagnosis and underreporting. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.

Entities:  

Keywords:  United States; costs and cost analysis; deaths; hospitalization

Year:  2022        PMID： 35350173      PMCID： PMC8946773          DOI： 10.1093/ofid/ofac097

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  16 in total

1.  US database study: burden and healthcare resource utilization in adults with systemic endemic mycoses and aspergillosis.

Authors:  Anna Forsythe; Gareth Lewis; Robyn Jordan; George R Thompson
Journal:  J Comp Eff Res       Date:  2020-04-22       Impact factor: 1.744

2.  The economic costs to United States hospitals of invasive fungal infections in transplant patients.

Authors:  Joseph Menzin; Juliana L Meyers; Mark Friedman; Jonathan R Korn; John R Perfect; Amelia A Langston; Robert P Danna; George Papadopoulos
Journal:  Am J Infect Control       Date:  2010-10-20       Impact factor: 2.918

3.  Global burden of recurrent vulvovaginal candidiasis: a systematic review.

Authors:  David W Denning; Matthew Kneale; Jack D Sobel; Riina Rautemaa-Richardson
Journal:  Lancet Infect Dis       Date:  2018-08-02       Impact factor: 25.071

4.  Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.

Authors:  Scott D Grosse; Kurt V Krueger; Jamison Pike
Journal:  J Med Econ       Date:  2018-11-15       Impact factor: 2.448

5.  Foodborne illness acquired in the United States--unspecified agents.

Authors:  Elaine Scallan; Patricia M Griffin; Frederick J Angulo; Robert V Tauxe; Robert M Hoekstra
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

Review 6.  Epidemiology of invasive fungal diseases on the basis of autopsy reports.

Authors:  María Cecilia Dignani
Journal:  F1000Prime Rep       Date:  2014-09-04

7.  Estimating influenza disease burden from population-based surveillance data in the United States.

Authors:  Carrie Reed; Sandra S Chaves; Pam Daily Kirley; Ruth Emerson; Deborah Aragon; Emily B Hancock; Lisa Butler; Joan Baumbach; Gary Hollick; Nancy M Bennett; Matthew R Laidler; Ann Thomas; Martin I Meltzer; Lyn Finelli
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

Review 8.  Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review.

Authors:  Mathilde Pivette; Judith E Mueller; Pascal Crépey; Avner Bar-Hen
Journal:  BMC Infect Dis       Date:  2014-11-18       Impact factor: 3.090

9.  Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis.

Authors:  Amy J Grizzle; Leslie Wilson; David E Nix; John N Galgiani
Journal:  Open Forum Infect Dis       Date:  2020-12-28       Impact factor: 3.835

10.  Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018.

Authors:  Emily Rayens; Karen A Norris
Journal:  Open Forum Infect Dis       Date:  2022-01-10       Impact factor: 3.835
View more
  4 in total

1.  Low Sensitivity of International Classification of Diseases, Tenth Revision Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019-2020.

Authors:  Kaitlin Benedict; Jeremy A W Gold; Emily N Jenkins; Jeremy Roland; Devra Barter; Christopher A Czaja; Helen Johnston; Paula Clogher; Monica M Farley; Andrew Revis; Lee H Harrison; Laura Tourdot; Sarah Shrum Davis; Erin C Phipps; Christina B Felsen; Brenda L Tesini; Gabriela Escutia; Rebecca Pierce; Alexia Zhang; William Schaffner; Meghan Lyman
Journal:  Open Forum Infect Dis       Date:  2022-09-07       Impact factor: 4.423

Review 2.  Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications.

Authors:  Tammy Haro-Reyes; Lucero Díaz-Peralta; Arturo Galván-Hernández; Anahi Rodríguez-López; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  Membranes (Basel)       Date:  2022-06-30

Review 3.  Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.

Authors:  Samantha L Williams; Tom Chiller
Journal:  J Fungi (Basel)       Date:  2022-06-25

Review 4.  Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials.

Authors:  John N Galgiani; Lisa F Shubitz; Marc J Orbach; M Alejandra Mandel; Daniel A Powell; Bruce S Klein; Edward J Robb; Mana Ohkura; Devin J Seka; Thomas M Tomasiak; Thomas P Monath
Journal:  J Fungi (Basel)       Date:  2022-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.